1. Augood CA et al. Prevalence of age-related maculopathy in older Europeans. Arch Ophthalmol. 2006; 124: 529-535.
  2. Vision Problems in the US: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America. 4th ed. Prevent Blindness America, 2008.
  3. Solomon SD et al. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration (Review). The Cochrane Library. 2014; 8: 1-155.
  4. de Jong P. Age-related macular degeneration. NEJM. 2006; 355(14): 1474-1485.
  5. Ferris FL et al. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984; 102: 1640-1642.
  6. Chopdar A et al. Age related macular degeneration. BMJ. 2003; 326: 485-488.
  7. Bressler NM. Early detection and treatment of neovascular age-related macular degeneration. J Am Board Fam Pract. 2002; 15: 142-152.
  8. Williams RA et al. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998; 116: 514-520.
  9. American Academy of Ophthalmology. Preferred Practice Pattern. Age-related macular degeneration. 2015.
  10. Coleman HR et al. Age-related macular degeneration. Lancet. 2008; 372: 1835-1845.
  11. Wong WL et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014; 2:e106-16.
  12. Fine SL et al. Age-related macular degeneration. NEJM. 2000; 342: 483-492.
  13. Seddon JM et al. The US twin study of age-related macular degeneration. Arch Ophthalmol. 2005; 123: 321-327.
  14. Klein R et al. Ten-year incidence and progression of age-related maculopathy. Ophthalmology. 2002; 109: 1767-1779.
  15. 1Klein R et al. Prevalence of age-related maculopathy. Ophthalmology. 1992; 99: 933-943.
  16. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001; 119: 1417-1436.
  17. Moutray T, Chakravarthy U. Age related macular degeneration (AMD): clinical features and clinical management. International Agency for the Prevention of Blindness. 2013.
  18. Kaiser PK. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension TAP Report No. 8. Graefe’s Arch Clin Exp Ophthalmol. 2006; 244: 1132–1142.
  19. LUCENTIS® Summary of Product Characteristics. Novartis AG; Sept. 2015.
  20. Brody BL et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001; 108: 1893-1901.
  21. Mayo Clinic Staff. Lifestyle and home remedies. degeneration/basics/lifestyle-home-remedies/con-20043518 (Accessed March 2016).
  22. Victoria State Government. Better Health Channel. Vision loss and cooking. https://www.betterhealth. (Accessed March 2016).


  1. Ciulla TA, et al. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003; 26: 2653-2664.
  2. National Eye Institute. Facts About Diabetic Retinopathy. 2011. (Accessed March 2016).
  3. Fareed A. A review of diabetic macular edema. Digital Journal of Ophthalmology. 1997; volume 3; number 6.
  4. Watkins PJ. Retinopathy. BMJ. 2003; 326: 924-926.
  5. American Diabetes Association. Living with diabetes. 2011. (AccessedMarch 2016).
  6. Canadian Diabetes Association. Diabetes and you: vision health. 2011. (Accessed March 2016).
  7. Royal College of Ophthalmology. Diabetic Retinopathy Guidelines. 2012. pdf (Accessed March 2016).
  8. Varma R, et al. Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States. Ophthalmology. 2015; 122(5):982-989.
  9. Revisiting DME. Available at March 2016).
  10. Eyre H and Kahn R. Preventing cancer, cardiovascular disease, and diabetes. Diabetes Care. 2004; 27: 1812-1824.
  11. National Diabetes Information Clearinghouse. Prevent diabetes problems: Keep your diabetes under control. 2008; NIH Publication No. 08-4349.
  12. Mayo Clinic Staff. Lifestyle and home remedies. (Accessed March 2016).
  13. WHO. Fact sheet 312: Diabetes. 2011. Available at (Accessed March 2016).
  14. LUCENTIS® Summary of Product Characteristics. Novartis AG; Sept.
  15. Hariprasad SM, et al. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol. 2008; 92: 89-92.
  16. Victoria State Government. Better Health Channel. Vision loss and cooking. https://www.betterhealth. (Accessed March 2016).